GLG Life Techは3Qで12億ドルの収益を上げ,7%増加し,純利益は185万ドルで,500万ドルの買い戻しと全年高額ガイダンスを発表しました. GLG Life Tech posted $1.2B in Q3 revenue, up 7%, with $185M net income, and announced a $50M buyback and higher full-year guidance.

GLG Life Techは2025年第3四半期財務結果を報告し,同期比7%増加した12億ドルもの収益を示した. GLG Life Tech reported its 2025 third quarter financial results, showing revenue of $1.2 billion, a 7% increase from the same period last year. 純利益は1億8,500万ドルで,同比12%増加した.これはバイオ医薬品と医療機器部門の業績の向上によりもたらされた. Net income reached $185 million, up 12% year-over-year, driven by stronger performance in its biopharmaceutical and medical device segments. また,同社は5千万ドルの株式購入プログラムを発表し,その全年収入の指導を強化した. The company also announced a $50 million share buyback program and raised its full-year revenue guidance.